«Highly toxic marine natural products combined
with tumor targeting antibodies is a promising avenue to improve cancer treatments,» he says.
Not exact matches
The Kamens claim the main thing that distinguishes their foundation from other brain
tumor foundations is their focus on pediatric brain cancer specifically, as well as their close ties
with pharmaceutical and biotech companies working in the fields of immunotherapy and
target gene therapy.
The
targeted radiotherapy shrank
tumors for 71 % of patients who had already failed standard chemotherapy, but these results came from a small trial that started
with 30 patients and then added another 20 after positive data started rolling in.
Unlike conventional chemotherapies and radiation that indiscriminately eradicate fast - growing tissues and ravage people's bodies
with side effects, new therapies specifically
target tumors using tailored cells from individual patients.
The other two major
targets in the field, circulating
tumor cells and exosomes, come
with their own challenges.
«Indeed, in a second
tumor model of metastatic breast cancer, we demonstrated that mice treated
with the EphA2 -
targeting paclitaxel conjugate presented nearly no lung metastases, while a large numbers of lesions were observed in both untreated mice and in mice treated
with just paclitaxel.»
Similarly, it may be possible to identify and validate new
targets for drugs that would selectively kill
tumor cells
with a particular molecular context.
The authors suggest that therapies
targeting TP53 mutations may yield better clinical outcomes for patients
with HPV - inactive
tumors.
They are working together to mesh her identification of compounds that
target tumors with runaway Ras activity and
tumor data (analyzed by machine learning) to find patients who could benefit from these potential cancer drugs.
By hitting breast cancer cells
with a
targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women's Hospital (BWH) were able to
target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking
tumors in the lab and in pre-clinical models.
Looking to
target a key pathway in order to interfere
with the processes that lead to
tumor spread, a research team led by Irwin H. Gelman, Ph.D., of Roswell Park Cancer Institute (RPCI) has identified a new suppressor of cancer metastasis that may point the way toward development of more effective treatments for prostate cancers and other malignant solid
tumors.
The
tumor - cell survival factors uncovered by this study might one day be
targeted with drugs to further diminish people's risk of metastasis.
«Considering that PDPN is associated
with poor prognosis in GBM, CAR T - cell therapy that
targets this protein is promising for treatment of patients
with relapsed or resistant
tumors following first - line chemotherapy,» says Toshihiko Wakabayashi, a coauthor and the chair of Department of Neurosurgery Nagoya University School of Medicine.
«If we could load these virus shells
with a different cargo, say a drug, and
target it to a particular place in the body, such as a
tumor, it could then deliver the drug to just that specific location, making the drug more effective, or reducing side effects,» Lawrence said.
Importantly, while using rosiglitazone in conjunction
with targeted therapy reduced
tumor growth in both young and aged pre-clinical models, using rosiglitazone alone accelerated
tumor growth in young models, while inhibiting it in aged ones.
«Study identifies potential treatment
target for pancreatic cancer: Molecular signature found in 30 percent of PDAC
tumors associated
with more aggressive cancer.»
Researchers at the University of Cincinnati (UC) College of Medicine have shown that a new
targeted treatment could benefit patients
with certain pancreatic
tumors by preventing spread of the cancer and protecting their heart from damage — a direct result of the
tumor.
To that end, in collaboration
with the University of Zurich and MD Anderson Cancer Center, the researchers tested melanoma
tumor samples from human patients undergoing treatment
with the same
targeted therapies.
They identified ALK - positive mesotheliomas by immunohistochemistry; confirmed
with fluorescence in situ hybridization; and performed
targeted next - generation sequencing of
tumor DNA and RNA to get a full picture of the exact genetic rearrangement underpinning the disease.
Detecting the presence of
tumor estrogen or HER2 receptors
with PET scans would enable oncologists to examine all sites of cancer for each patient, choose the appropriate drug treatment more quickly, monitor the
tumor for changes that would necessitate a switch to another treatment, and even evaluate how well a drug is hitting its receptor
targets.
«Thanks to a deeper understanding of cancer biology, we have a potential new
targeted therapy for multiple myeloma, and can better tailor treatment for kids
with Wilms
tumor.
CTL119 manufacturing begins
with a patient's own T cells, some of which are removed and then reprogrammed in Penn's Clinical Cell and Vaccine Production Facility
with a gene transfer technique designed to teach the T cells to
target and kill
tumor cells.
«We wanted to utilize platelets» intrinsic tendencies to accumulate at wounds and to interact
with circulating
tumor cells, for
targeted delivery of immune checkpoint inhibitors» said Gu, «Interestingly, we found the antibody can be promoted to release from activated platelets in the surgical site, due to generation of small platelet - derived microparticles upon the platelet activation.
Blood testing showed an expansion in the numbers of CD19 -
targeted CAR T - cells that coincided
with the
tumor's regression.
«For men initially diagnosed
with low - risk prostate cancer, MRI - ultrasound confirmatory biopsy including
targeting of suspicious lesions seen on MRI results in frequent detection of
tumors,» the study states.
If metastatic cancers are most often made up of cells
with different genetic drivers, perhaps researchers should be
targeting the primary
tumor with multiple drugs to contain the cancer.
Second, we believe the vaccine may be particularly beneficial for a group of patients
with the HLA - A2 type, which suggests that as we move forward, there may be advantages in
targeting this population,» said John Yu, MD, vice chair of the Department of Neurosurgery, director of surgical neuro - oncology, medical director of the Brain
Tumor Center and neurosurgical director of the Gamma Knife Program at Cedars - Sinai.
There is no way to directly
target the loss of the
tumor suppressor, but Ler et al. found another strategy to effectively treat
tumors with this mutation.
The researchers first used yeast to quickly and cheaply screen 169,000 interactions between yeast versions of human
tumor - suppressor genes and genes that can be inhibited
with drugs, sometimes called «druggable»
targets.
Targeting Twist1 might silence MMP2 and decrease
tumor invasion, which will help patients
with GBM.
«This finding suggests a novel therapeutic
target to decrease invasion of
tumor cells in patients and may also provide a novel biomarker that could help predict survival of patients
with glioblastoma,» explained Israel.
And for more on molecularly
targeted cancer drugs, see the news story «Combining Targeted Drugs to Stop Resistant Tumors» (free full text with registration) in this week's issue of
targeted cancer drugs, see the news story «Combining
Targeted Drugs to Stop Resistant Tumors» (free full text with registration) in this week's issue of
Targeted Drugs to Stop Resistant
Tumors» (free full text
with registration) in this week's issue of Science.
«Identifying
targets essential to cell survival in
tumor suppressor genes has long been an investigational goal
with the aim of offering cancer - specific vulnerabilities for
targeted therapy,» said Ronald DePinho, M.D., professor of Cancer Biology, MD Anderson president, and senior author for the Nature paper.
In the group that received
targeted treatment for ALK - positive lung cancer, each category of
tumor reduction was associated
with corresponding gains in PFS and OS.
The findings suggest that
targeting newly discovered pathways could be an effective approach to improving the clinical outcome of patients
with BRAF inhibitor - resistant melanoma
tumors.
In their report that has received advance online publication in Nature Nanotechnology, a research team based at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) describes how a nanomedicine that combines photodynamic therapy — the use of light to trigger a chemical reaction —
with a molecular therapy drug
targeted against common treatment resistance pathways reduced a thousand-fold the dosage of the molecular therapy drug required to suppress
tumor progression and metastatic outgrowth in an animal model.
The light - sensitive cells and nanoparticles, called opto - CRAC, were then delivered
with the
tumor antigen surrogate ovalbumin to mice
with melanoma
tumors in their lymph nodes to see if an immune response could be activated to
target cancer cells.
The researchers hope that a better understanding of how Ras proteins cluster together and interact
with other proteins in cells will bring them one step closer to developing therapeutic
targets for Ras - driven
tumors.
During the last three years the Spanish Consortium for the Study of the Genome of the Chronic Lymphatic Leukemia, where the researchers of the present study already collaborate, has sequenced the genome of hundreds of patients
with the more common leukemia in our society, identifying new mechanisms of
tumor progression and new therapeutic
targets.
For example, drugs that
target a specific BRAF gene mutation commonly found in melanoma shrink
tumors in about half of patients
with the mutation.
Scientists hope to
target these sites of
tumor growth
with therapies that can control abdominal
tumors and assist anti-
tumor immunity.
The
targeted particles
with the passports shrank
tumors by 25 % in a single day, while nanoparticles
with the antibodies but without the peptide passports had no effect on the
tumor size.
Reactivation of HBV may occur
with chemotherapy, organ and tissue transplantation, High dose corticosteroids, and biologicals
targeting tumor necrosis factor - alpha (TNF - α), Anti-TNF medications are used in treating rheumatic diseases, such as rheumatoid arthritis, digestive conditions that include Crohn's and colitis, and dermatologic conditions, such as psoriasis.
The project builds on Dr. Slamon's previous work partially funded by CIRM to develop a drug that
targets tumor initiating cells
with UCLA's Dr. Zev Wainberg, assistant professor of hematology / oncology and Dr. Tak Mak, director, Campbell Family Institute of the University Health Network in Toronto, Canada.
«First drug
target identified for children
with rare type of brain
tumor.»
They confirmed this by showing that
tumor growth was reduced in mice treated
with an antibody drug that
targets TIM - 3 and the chemotherapy agent paclitaxel, as compared to treatment
with paclitaxel alone.
«The key to taking cancer vaccines to another level is combining them
with immunotherapies that
target the
tumor microenvironment,» Kwak said.
In fact, the mice that received the complete nanomedicine package had smaller
tumors and longer lifespans than their counterparts injected
with saline, nanoparticles without the drug, the drug alone, and nanoparticles
with the drug but without the
targeting aptamers.
Keytruda is the first approved drug that
targets tumors with specific biomarkers, rather than based solely on their tissue origin (i.e. breast, lung, or colon).
Scientists have found a way to
target elusive cells that suppress immune response, depleting them
with peptides that spare other important cells and shrink
tumors in preclinical experiments, according to a paper published online by Nature Medicine.